Skip to main content
SpringerLink
Log in

Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

This study was undertaken to evaluate the colorimetric MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium bromide] assay as a means of testing the sensitivity of gliomas to chemotherapeutic agents in vitro. Eight human glioma established cell lines were plated in 96-well tissue culture plates and incubated for 4 days with 10 different anti-cancer agents; 5 different concentrations of each drug were tested. The MTT dye was then added to the wells, and the resulting formazan precipitate was solubilized with dimethylsulfoxide (DMSO). The spectrophotometric absorbance (measured at 570 nm) of control and experimental wells was used to calculate the cytotoxicity index (CI). Values with a CI greater than 50% growth inhibition indicated cytotoxic efficacy (sensitivity to the chemotherapeutic drug).

Six of the seven (85.7%) glioma cell lines were highly sensitive at varying concentrations to mitomycin C, cisplatin, and doxorubicin. Four of the seven (57.1%) cell lines demonstrated intermediate sensitivity to mitoxantrone and vinblastine. Five of the seven (71.4%) cell lines exhibited resistance to etoposide, bleomycin, cosmegen, and BCNU. One of the cell lines tested, U-138MG, failed to produce the MTT formazan precipitate, so that the sensitivity of this cell line to the panel chemotherapeutic drugs could not be determined. The variability of the results indicates the need for an in vitro screening method to evaluate the effectiveness of clinical and experimental chemotherapeutic agents. The MTT assay provides a rapid method of screening antineoplastic agents against gliomas for cytotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1–17, 1988

    Google Scholar 

  2. Hill BT: Use of continuous human tumor cell lines to evaluate drugs by clonogenic assays. In: Dendy PP and Hill BT (eds) Human Tumor Drug Sensitivity Testing in vitro, Academic Press, London 129–146, 1983

    Google Scholar 

  3. Courtenay VD, Mills J: An in vitro colony assay for human tumors grown in immune-suppressed mice and treated in vivo with cytotoxic agent. Br J Cancer 37: 261–268, 1978

    Google Scholar 

  4. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197: 461–463, 1977

    Google Scholar 

  5. Alley MC, Lieber MM: Improved optical detection of colony enlargement and drug cytotoxicity in primary soft agar cultures of human solid tumor cells. Br J Cancer 49: 225–233, 1984

    Google Scholar 

  6. Bertoncello I, Bradley TR, Campbell JJ, Day AJ, McDonald IA, McLeish GR, Quinn MA, Rome R, Hodgson GS: Limitations of the clonal agar assay for the assessment of primary human ovarian tumor biopsies. Br J Cancer 45: 803–811,1982

    Google Scholar 

  7. Kubota T, Kawamura E, Kurihara H, Ishibiki K, Abe O, Suzuki T, Suzuki Y, Yamada T: Clonogenic assay as the in vitro chemosensitivity test. In: Ishigami J (ed) Recent Advances in Chemotherapy, Anticancer Section, University of Tokyo Press, Tokyo 288–289, 1985

    Google Scholar 

  8. Selby P, Bizzari JP, Buick RN: Therapeutic implications of a stem cell model for human breast cancer: a hypothesis. Cancer Treat Rep 67: 659–663, 1983

    Google Scholar 

  9. Von Hoff DD, Clark GM, Stogdill BJ, Sarodsy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF: Prospective clinical trial of a human tumorcloning system. Cancer Res 43: 1926–1931, 1983

    Google Scholar 

  10. Weisenthal LM, Marsden JA, Dill PL, Macaluso CK: A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43: 749–757, 1983

    Google Scholar 

  11. Kirkpatrick DL, Duke M, Goh TS: Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leukemia Res 14 (5):459–466,1990

    Google Scholar 

  12. Pieters R, Huismans DR, Leyva A, Veerman AJP: Comparison of the rapid automated MTT assay with a dye exclusion assay for chemosensitivity testing in childhood leukemia. Br J Cancer 59: 217–220, 1989

    Google Scholar 

  13. Bird MC, Godwin VAJ, Antrobus JH, Bosanquet AG: Comparison of in vitro drug sensitivity by the differential staining cytotoxicity (DiSC) and colony-forming assays. Br J Cancer 55: 429–431, 1987

    Google Scholar 

  14. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semi-automatic colorimetric assay. Cancer Res 47: 943–946, 1987

    Google Scholar 

  15. Laurent G, Kuhlein E, Casellas P, Canat X, Carayon P, Poncelet P, Correll S, Rigal F, Jansen FK: Determination of sensitivity of fresh leukaemia cells to immunotoxins. Cancer Res 46: 2289–2294, 1986

    Google Scholar 

  16. Weisenthal LM, Dill PL, Kurnick NB, Lippman ME: Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res 43:258–264,1983

    Google Scholar 

  17. Bird MC, Bosanquet AG, Forskitt S, Gilby ED: Long-term comparison of results of an in vitro drug sensitivity assay with patient response in lymphatic neoplasms. Cancer 61: 1104–1109,1988

    Google Scholar 

  18. Bosanquet AG, Bird MC, Price WJP, Gilby ED: An assesment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. Br J Cancer 47: 781–789, 1983

    Google Scholar 

  19. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271–277, 1986

    Google Scholar 

  20. Black MM, Speer FD: Further observations on the effects of cancer chemotherapeutic agents in the in vitro dehydrogenase activity of cancer tissue. J Natl Cancer Inst 14: 1147–1158,1954

    Google Scholar 

  21. Kondo T, Ohkubo K: In vitro test for prediction of side effects of carcinostatic agents. Gann 58 (4): 349–354, 1967

    Google Scholar 

  22. Adams GE, Stratford IJ, Wallace RG, Wardman P, Watts ME: Toxicity of nitro compounds toward hypoxic mammalian cells: dependence upon reduction potential. J Natl Cancer Inst 64: 555–560, 1980

    Google Scholar 

  23. Harker WG, Slade DL, Lund K: In vitro doxorubicin (DOX) sensitivity of human and murine cell lines: Comparison of clonogenic and MTT assays. Proc Am Assoc Cancer Res 28: 420–427, 1987

    Google Scholar 

  24. Kennedy KA, Teicher BA, Rockwell S, Sartorelli A: The hypoxic tumour cell: A target for selective cancer chemotherapy. Biochem Pharmacol 29: 1–7, 1980

    Google Scholar 

  25. Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O: Predictability of in vivo chemosensitivity by in vitro assay with reference to the clonogenic assay. J Surg Oncol 41: 12–18,1989

    Google Scholar 

  26. Alley MC, Scudiero DA, Monks A, Huyrsey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay. Cancer Res 48: 589–601, 1988

    CAS  PubMed  Google Scholar 

  27. Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD: Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer 57 (6): 540–547, 1988

    Google Scholar 

  28. Cole SPC: Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17: 259–263, 1986

    Google Scholar 

  29. Finlay GJ, Wilson WR, Baguley BC: Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines. Eur J Cancer Clin Oncol 22: 655–662,1986

    Google Scholar 

  30. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF: Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium based colorimetric assay. Cancer Res 47: 5875–5879, 1987

    Google Scholar 

  31. Twentyman PR, Luscombe M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56: 279–285, 1987

    Google Scholar 

  32. Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, Alken P: Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol Res 18 (2): 131–136, 1990

    Google Scholar 

  33. Suto A, Kubota T, Shimoyama Y, Ishibiki K, Abe O: MTT assay with reference to the clinical effect of chemotherapy. J Surg Oncol42: 28–32, 1989

    Google Scholar 

  34. Wilson JK, Sargent JM, Elgie AW, Hill JG, Taylor CG: A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br J Cancer 62: 189–194, 1990

    Google Scholar 

  35. Hongo T, Fujii Y, Igarashi Y: An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65: 1263–1271, 1990

    Google Scholar 

  36. Sargent JM, Taylor CG: Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60: 206–210, 1989

    Google Scholar 

  37. Twentyman PR, Fox NE, Rees JKH: Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol 71: 19–24, 1989

    Google Scholar 

  38. Boyd MR: Status of the NCI preclinical antitumor drug discovery screen. Principles & Practices of Oncology 3 (10): 1–12,1989

    Google Scholar 

  39. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH, Boyd MR: New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of syn thetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81(8): 577–586, 1989

    Google Scholar 

  40. Sasaoka N: Chemosensitivity assays for malignant gliomas. Gan-To-Kagaku-Ryoho 17 (11): 2247–2252, 1990

    Google Scholar 

  41. Yung WK: In vitro chemosensitivity testing and its clinical application in human gliomas. Neurosurgical Review 12 (3):197–203,1989

    Google Scholar 

  42. Hubbell HR, Liu RS, Maxwell BL: Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA. Cancer Res 44 (8): 3252–3257, 1984

    Google Scholar 

  43. Dick RS, Hubbell HR: Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations. J Neuro Oncol 5: 331–338, 1987

    Google Scholar 

  44. Giard DJ, Aaronson SA: In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417–1423, 1973

    CAS  PubMed  Google Scholar 

  45. Gross JL, Behrens DL, Mullins DE, Kornblith PL, Dexter DL: Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res 48: 291–296, 1988

    Google Scholar 

  46. Ponten J, MacIntyre EH: Long term culture of normal and neoplastic human glia. Acta Path Microbiol Scand 74: 465–486,1968

    Google Scholar 

  47. Tepe P, Hassenbusch SJ, Benoit R, Anderson JH: BCNU stability as a function of ethanol concentration and temperature. J Neuro-Oncol 10: 121–127, 1991

    Google Scholar 

  48. Levin VA, Levin EM: Dissolution and stability of carmustine in the absence of ethanol. Selective Cancer Therapeutics 5 (1): 33–35, 1989

    Google Scholar 

  49. Metcalfe SA: A review of methods for estimating clinically achievable antitumour drug levels and their association with studies in vitro. In: Dendy PP, Hill BT (eds) Human Tumour Drug Sensitivity Testing In Vitro. Academic Press: London 213–224,1983

    Google Scholar 

  50. Durkin WJ, Ghanta VK, Hiramoto RN: Results obtained using a vital dye exclusion assay and clinical correlations. In: Dendy PP and Hill BT (eds) Human Tumor Drug Sensitivity Testing In Vitro. Academic Press, London 259–268, 1983

    Google Scholar 

  51. Green LM, Reade JL, Ware CF: Rapid colorimetric assay for cell viability: Application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70:257–268,1984

    Google Scholar 

  52. Kornblith PL, Szypko PE: Variations in response of human brain tumors to BCNU in vitro. J Neurosurg 48: 580–586, 1978

    Google Scholar 

  53. Kimmel DW, Shapiro JR, Shapiro WR: In vitro drug testing in human gliomas. J Neurosurg 66: 161–171, 1987

    Google Scholar 

  54. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63, 1983

    Article  PubMed  Google Scholar 

  55. Yung WK, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42: 992–998, 1982

    Google Scholar 

  56. Vistica DT, Skehan P, Schudiero DA, Monks A, Boyd MR: Tetrazolium-based assays for cellular viability: A critical examination of parameters which affect formazan production. Proc Am Assoc Cancer Res 30: 2437, 1989

    Google Scholar 

  57. Packer RJ: Prognostic factors in patients with brain tumors. In: Salcman M (ed) Neurobiology of Brain Tumors, Vol 4, Williams & Wilkins, Baltimore, 275, 1991

    Google Scholar 

  58. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y: Comparison of post-operative radiotherapy and combined post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997–1007,1983

    Google Scholar 

  59. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K: Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of post-operative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicentered trial of the Scandinavian glioblastoma study group. Cancer 47: 649–652, 1981

    Google Scholar 

  60. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329, 1980

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Hahnemann University, Philadelphia, PA, USA

    Joseph P. Jordan, Christopher M. Hand, Ronald S. Markowitz & Perry Black

Authors
  1. Joseph P. Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher M. Hand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald S. Markowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Perry Black
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jordan, J.P., Hand, C.M., Markowitz, R.S. et al. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J Neuro-Oncol 14, 19–35 (1992). https://doi.org/10.1007/BF00170942

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00170942

Key words

Search

Navigation